Triclear-SA by Trikona Pharmaceuticals was recognised for “Innovation in Anti-Acne Solutions” at the Aesthetic Medicine India Conference 2025. The event, which was held in Mumbai on June 9, 2025, brought together top dermatologists, aesthetic practitioners, and industry leaders to honour excellence in clinical skincare innovation.
Moreover, Trikona sets new standards in acne care by delivering a science-backed formulation designed for practical, everyday use. Acne continues to be one of the most common skin concerns, affecting individuals across age groups.
However, while the market is flooded with topical solutions, few stand out for their science-backed efficacy and user-friendly formulation. In this context, Triclear-SA, developed by Trikona Pharmaceuticals, is one such innovation that’s redefining the treatment of mild to moderate acne and blemishes.
Advanced formulation for targeted acne care
Triclear-SA is a dermatologist-formulated, bioactive acne care cream designed to treat mild to moderate acne and blemishes. It combines Bio-Succinic Acid, Mandelic Acid, HPPA, and Squalane Cream to address key acne triggers at the source.
Specifically, the formulation works by:
Regulating excess sebum production
Reducing inflammation
Promoting skin renewal
Improving overall skin texture
Unlike traditional treatments, Triclear-SA uses a gentle yet effective multi-ingredient blend to treat acne, avoiding the harsh actives found in conventional formulations.
Easy application meets dermatological precision
Furthermore, Triclear-SA features a long-nozzle design that lets users apply it precisely to affected areas with minimal skin contact. It’s recommended for use twice daily or as advised by a dermatologist.
As a result, dermatologists favour Triclear-SA for its elegant formulation and targeted application, offering practical, result-driven solutions for patients.
Recognition for evidence-based skincare
Trikona Pharma is a trusted leader in dermatology-focused pharmaceutical manufacturing, offering pharmaceutical-grade skincare for conditions like acne, eczema, psoriasis, and more. In addition, the company is committed to clinical dermatology and medical cosmetology, delivering products that meet global quality standards.
Ultimately, Triclear-SA’s recognition at AMI 2025 highlights Trikona Pharmaceuticals’ dedication to research-driven innovation. The honour acknowledges the brand’s contribution to developing modern, clinically sound solutions that align with evolving skincare needs.